Cardiovascular Research Centre (CVRC) - translational cardiovascular research

Cardiovascular and haematological diseases, such as arrhythmias, myocardial infarction, thrombosis, bleeding, haematological cancer diseases and heart failure are common causes of death in the industrialised Western world and the cost for the society and the health care system to treat these diseases is tremendous. It is of main importance to strengthen research activities to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of these diseases.

Group information

Contact

Magnus Grenegård

Research subject

Cardiovascular Research Centre (CVRC) is a translational cardiovascular research group forming a network at Örebro University and Örebro University Hospital/Region Örebro County working with basic, translational and clinical research to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of cardiovascular and haematological diseases.

The overall strategy for CVRC is to support internal and external academic and industrial research collaboration and to contribute to a successful and high-quality third cycle education in the field of cardiovascular research. A main task of this larger research group is to support younger employees active in the cardiovascular and inflammatory research fields through cross-group activities such as journal clubs, research discussions and research meetings. Individual projects and connected research groups are also considered to have a particularly great benefit from these activities. Increased collaboration also promotes the emergence of completely new research projects with translational research design. The CVRC has been ranked as a strong research environment by external evaluators.

You may find more detailed information regarding the researchers and different research projects performed by the network by clicking at the tab “Researchers” and “Research projects” above.